NCT01052987 - Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions

GoutHyperuricemia

Interventions

DRUG

Tranilast

Tranilast tablets, 300 mg, QD

DRUG

Allopurinol

Allopurinol tablets 300 mg, QD

DRUG

Combination - Tranilast and Allopurinol

Tranilast, 300 mg QD; Allopurinol 300 mg QD

DRUG

400 mg Allopurinol

400 mg Allopurinol administered once daily for 7 days

DRUG

High dose combination

Combination of Tranilast 300 mg once daily for 7 days plus Allopurinol 400 mg once daily for 7 days

Trial Locations (3)

Nuon Investigative Site, Honolulu

Nuon Investigative Site, Evansville

Nuon Investigative Site, Dallas